8-KThe WireRed Alert
Executive Change
Filed Aug 16, 2021 · 4y ago · Accession 0001104659-21-106259
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): August 13, 2021
VEECO INSTRUMENTS INC.
(Exact name of registrant as specified in
its charter)
Delaware
(State or other jurisdiction
of incorporation)
0-16244
(Commission
File Number)
11-2989601
(IRS Employer
Identification No.)
Terminal Drive , Plainview , New York 11803
(Address of principal executive offices)
( 516 ) 677-0200
(Registrant’s telephone number,
including area code)
Not applicable
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered
pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
VECO
The NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of New Director
On August 13, 2021, Veeco’s Board of Directors voted to increase
the size of the Board from eight to nine directors and to appoint Sujeet Chand as a Class I director, to hold office until the 2022 Annual
Meeting of Stockholders. The increase in Board size and Dr. Chand’s appointment will both become effective as of August 16, 2021.
Dr. Chand, who self-identifies as an Asian American male, was identified through a search process which was commenced earlier this year
in connection with the Board’s desire for increased racial or ethnic diversity. The search process was led by the Governance Committee
and used the services of an outside search firm.
Dr. Chand, age 63, has served as Senior Vice President and Chief Technology
Officer of Rockwell Automation since 2005. From 2001 to 2005, Dr. Chand served as Rockwell Automation’s Vice President, Control
Systems. Prior to joining Rockwell Automation, Dr. Chand served as Chief Operating Officer for XAP Corporation from 1999 to 2001 and,
from 1988 to 1999, Dr. Chand led research & development at Rockwell Scientific Company, a subsidiary of Rockwell International. Dr.
Chand holds a Bachelor of Engineering degree from Osmania University and, from the University of Florida, a Masters Degree in Electrical
Engineering and a Ph.D. in Electrical and Computer Engineering.
Consistent with Veeco’s director compensation policy, Dr. Chand
was granted restricted shares of Veeco common stock having a value of $140,000, the restrictions on which will lapse on the earlier to
occur of: (i) the date immediately preceding the date of Veeco’s 2022 Annual Meeting of Stockholders and (ii) the first anniversary
of the award date.
Veeco also entered into its standard form of indemnification agreement
with Dr. Chand on substantially the same terms as those entered into with our other directors and executive officers.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
August 13, 2021
VEECO INSTRUMENTS INC.
By:
/s/ Kirk Mackey
Name: Kirk Mackey
Title: Vice President, General Counsel
3
Filing details
- Company
- VEECO INSTRUMENTS INC
- Ticker
- VECO
- CIK
- 103145
- Form type
- 8-K
- Filing date
- Aug 16, 2021
- Report date
- Aug 13, 2021
- Document
- tm2125178d1_8k.htm
- Size
- 192 KB